Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
Krop, I.E., Lin, N.U., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D., Samant, M., Welslau, M., Diéras, V.
Published in Annals of oncology (01.01.2015)
Published in Annals of oncology (01.01.2015)
Get full text
Journal Article
Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial
Riese, C., Weiß, B., Borges, U., Beylich, A., Dengler, R., Hermes-Moll, K., Welslau, M., Baumann, W.
Published in Supportive care in cancer (01.11.2017)
Published in Supportive care in cancer (01.11.2017)
Get full text
Journal Article
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
Heidenreich, A., Rawal, S.K., Szkarlat, K., Bogdanova, N., Dirix, L., Stenzl, A., Welslau, M., Wang, G., Dawkins, F., de Boer, C.J., Schrijvers, D.
Published in Annals of oncology (01.02.2013)
Published in Annals of oncology (01.02.2013)
Get full text
Journal Article
P1171: REFLECT: PROSPECTIVE NON‐INTERVENTIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF SANDOZ RITUXIMAB (SDZ‐RTX) WITH CHOP FOR PATIENTS WITH PREVIOUSLY UNTREATED CD20‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA
Welslau, M., Kubuschok, B., Topaly, J., Otremba, B., Wolff, T., Bryn, G.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
Palbociclib in combination with letrozole as first or later line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study
Welslau, M.K., Zaiss, M., Söling, U., Untch, M., Müller, L., Lüftner, D., Meiler, J., Welt, A., Sahlmann, J., Houet, L., Runkel, E., Marschner, N.W.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study
Hecht, M., Hahn, D., Wolber, P., Hautmann, M., Reichert, D., Weniger, J., Belka, C., Bergmann, T., Göhler, T., Welslau, M.K., Hofmann, D., Fiektkau, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
SANDOZ RITUXIMAB FOR TREATMENT OF DIFFUSE LARGE B‐CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE NON‐INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN‐LABEL REFLECT STUDY
Welslau, M., Marschner, N., Wolff, T., Otremba, B., Topaly, J., Bittencourt da Silva, L.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison
Herth, I., Dietrich, S., Benner, A., Hegenbart, U., Rieger, M., Stadtherr, P., Bondong, A., Tran, T.H., Weide, R., Hensel, M., Knauf, W., Franz-Werner, J., Welslau, M., Procaccianti, M., Görner, M., Meissner, J., Luft, T., Schönland, S., Witzens-Harig, M., Zenz, T., Ho, A.D., Dreger, P.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
Hofheinz, R.-D., Herrle, F., Dechow, T., von Weikersthal, L.F., Welslau, M., Lettmaier, S., Burkart, C., Kubicka, S., Kochen, L., Merx, K., Krause, K., Ebert, M., Rödel, C., Fokas, E., Ghadimi, M., Reissfelder, C., Gaiser, T.
Published in ESMO open (01.09.2024)
Published in ESMO open (01.09.2024)
Get full text
Journal Article
P636: REAL WORLD OUTCOME WITH IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA FROM THE GERMAN REALITY STUDY
Welslau, M., Schlag, R., Heinrich, B., Vornholz, L., Buchholz, S., Marquard, B., Dörfel, S., Anke, G.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
Impact of trastuzumab treatment beyond disease progression for advanced/metastatic breast cancer on survival – Results from a prospective, observational study in Germany
Jackisch, C, Welslau, M, Schoenegg, W, Selbach, J, Harich, H.-D, Schröder, J, Schmidt, M, Göhler, T, Eustermann, H, Ringel, R, Hinke, A
Published in Breast (Edinburgh) (01.10.2014)
Published in Breast (Edinburgh) (01.10.2014)
Get full text
Journal Article
Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer
Modi, N.D., Danell, N.O., Perry, R.N.A., Abuhelwa, A.Y., Rathod, A., Badaoui, S., McKinnon, R.A., Haseloff, M., Shahnam, A., Swain, S.M., Welslau, M., Sorich, M.J., Hopkins, A.M.
Published in ESMO open (01.06.2022)
Published in ESMO open (01.06.2022)
Get full text
Journal Article
5072 POSTER First-Line Bevacizumab (Bev) Combined With Paclitaxel (pac) in Older Patients (pts) Treated for HER2-Negative Metastatic Breast Cancer (mBC) in a Routine Oncology Practice Study
Foerster, F, Aktas, B, Geberth, M, Tschechne, B, Schneeweiss, A, Salat, C, Tesch, H, Welslau, M, Schmidt, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
Kollmannsberger, C, Rick, O, Klaproth, H, Kubin, T, Sayer, H G, Hentrich, M, Welslau, M, Mayer, F, Kuczyk, M, Spott, C, Kanz, L, Bokemeyer, C
Published in British journal of cancer (23.09.2002)
Published in British journal of cancer (23.09.2002)
Get full text
Journal Article
802P Real-world data of olaparib maintenance therapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer: Final results of the C-PATROL study
Marmé, F., Hilpert, F., Welslau, M., Grabowski, J.P., Schneeweiss, A., Hartkopf, A.D., Becker, S., Runnebaum, I., Bauerschlag, D., Fasching, P., Brandi, C., Rehbein, J-K., Glowik, R., Sehouli, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Interim results of the non-interventional C-PATROL study: Real-world treatment data from patients who switched from olaparib capsules to tablets
Marmé, F., Hilpert, F., Welslau, M., Grabowski, J.P., El-Balat, A., Hartkopf, A.D., Glowik, R., Sehouli, J.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA
von der Heyde, E., Welslau, M., Gauler, T., Rothnie, K., Waldenberger, D., Dietz, A.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
Olaparib in German routine clinical practice: Updated interim results of the non-interventional study c-patrol
Sehouli, J., Hilpert, F., Welslau, M., Schinköthe, T., Glowik, R., Marmé, F.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article